ANGARA - AI/b2b SaaS/Climate - Non NDA
Overview
🚀 COMPANY: ANGARA Global - a U.K. tech company with offices in Amsterdam and Bahrain.
➡️ THEMES: #B2B SaaS #Artificial Intelligence #Energy #Decarbonization #Revenue-generating #Series A
❇️ HIGHLIGHTS
• Problem: industrial asset inefficiencies result in $100 billion in annual losses plus 1 billion mtCO2 emissions - caused by fouling alone
• Our solution: we built and commercialized an AI-automated digital platform to orchestrate industrial asset efficiency risks to boost clients' margins and reduce CO2.
It is already profitable for us at selected customers and is being deployed company-wide at some of them.
The underlying technology is protected by 40 issued patents ; another 20+ are pending.
• Competitive advantage:
A. Superior prediction accuracy and
B. Forecasting horizon which is 3-7 times greater than that of our competitors
• Customers include Fortune Top 25 companies, e.g. ExxonMobil and TotalEnergies
• Shareholders invested $13 mln. and include:
- Bank of America, Executive Vice Chairman (current) and Global Head, Natural Resources & Energy Transition (ex);
- McKinsey & Company, Global Head for Oil and Gas (ex);
- The White House, Special Adviser to the US President (ex);
- J.P. Morgan, Global Head of Sustainability and Energy (ex);
- F4SE, a VC from Singapore.
• Experienced board and management: NEDs with global experience as top executives of multi-billion dollar companies, including experience as CEO of a $10+ billion public company.
The Founders
- Worked as a team for 6+ years;
- Prior to ANGARA - McKinsey, Morgan Stanley, IBM, IHS, Halliburton.;
- Invested $3.2 mln. in cash in ANGARA;
- A clear vision for a 2-stage $1+ billion EXIT.
• TAM / Total Available Market exceeds $50 billion by 2033
💹 Application Markets: agriculture/food processing, fertilizers, biofuels, oil & gas, petrochemicals, chemicals, power generation, desalination, etc.
🌎 Geography: already used in the EU, Middle East, FSU. Preparing to start sales in the USA and SEA in 2025.
🏆 UNIQUENESS and ADVANTAGE:
Our AI models predict performance with a
(1) higher accuracy and
(2) much farther forecasting horizon of 10-15 months vs. of 2-4 months.
(3) On top of that, our AI automatically generates practical action plans.
👨👩👧👦 TEAM:
Experienced team with prior experience in McKinsey, Morgan Stanley, IBM, IHS, Halliburton.
The founders had successful exits in the US
and worked together for 6+ years.
The Board includes 2 NEDs:
• Panos Cavoulacos (US): Schlumberger, Booz, Hellenic (CEO), McKinsey (ex);
• Jaap Kalkman (Netherlands), Group Chief Investment Officer at ADQ (current), ADL, McKinsey, Roland Berger (ex).
📊 TRACTION:
• $1 mln. in sales in 2023, $5 mln. in the next 12 months.
• Metis Partners (a leading IP expert company) valued our 40 issued patents at $23 mln.
• Customers include Fortune Top 25 companies, e.g. ExxonMobil and TotalEnergies.
• DNV confirmed the technology’s maturity at 8+ TRL; its 400 million tonnes/year CO2 reduction potential and safety.
• ANGARA is part of J.P. Morgan’s Green Economy Banking (and a client of J.P. Morgan).
💰 ROUND: Series A of $5-10 mln.
Use of funds: expand the team
• A. By 10+ people in tech support and deployment function to convert the current $18 mln. pipeline into $4.7 mln. of ARR in the next 12 months;
• B. To build the Frontend for our AI core to convert customers faster;
• C. To launch AI Agents to increase the robustness and versatility of our offering.
Options available: (i) Direct equity OR (ii) Convertible loan @15% p.a. and valuation cap.
✅ EXIT:
The base case EXIT scenario is 2-step:
(1): Interim partial EXIT within 1-2 years as a sale of Fouling Fracturing technology stack.
Potential $100-250 mln.
(2): Ultimate EXIT within 3-4 years as a sale of the business based on DecarbonX AI platform.
Potential $1-2 billion.
Problem and Solution
Proin auctor bibendum ex, non condimentum tortor sodales vitae. Ut feugiat at lorem accumsan consequat.
Suspendisse ac condimentum ipsum, sit amet auctor dui. Aliquam pretium justo in commodo varius.
Pellentesque elementum felis non urna vulputate, non posuere metus suscipit.
Aenean lacinia id quam a lobortis. Cras nibh lorem, vulputate eget purus elementum, pharetra condimentum elit.
Quisque et sagittis ex, vitae ultrices nulla. Vivamus dapibus blandit libero, et scelerisque dui ullamcorper ut. Vivamus ut molestie ex. Integer eget tempus mauris. Quisque volutpat pulvinar urna, posuere pharetra ex auctor vel. Sed id lacus tortor. Proin nisl turpis, tempus a leo in, lacinia volutpat orci.
Aenean nulla nibh, porta a dignissim vitae, laoreet vitae lacus. Nunc in aliquet urna. Vivamus vel turpis a mi consequat venenatis. Pellentesque tincidunt ante ut urna accumsan lacinia. Sed sed enim volutpat, malesuada metus ut, lobortis lectus. Sed vulputate fringilla justo, sed condimentum tellus fermentum sit amet. Pellentesque tempus elit id dapibus ornare. Phasellus accumsan suscipit elit. Donec eget libero eget neque cursus bibendum. Praesent lacinia felis et aliquam condimentum. Proin vestibulum posuere tortor at finibus. Etiam posuere neque eu elit sollicitudin sollicitudin. Sed viverra ante eros, et maximus tortor viverra et.
Quisque a nunc maximus, eleifend est eget, mattis mauris. Aliquam non eleif
Open an account to get
access to more details
Market Opportunity
Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet.
Vivamus maximus nulla volutpat, ornare lorem a, vulputate enim. In dui nisl, vestibulum eu finibus pretium, eleifend et eros. Vivamus in venenatis risus, ut dictum velit. Praesent rhoncus tempor fermentum. In malesuada tellus eu volutpat posuere. Nullam ut dignissim libero, ut pharetra leo. Nullam sit amet aliquam felis. Suspendisse volutpat ante eget tincidunt feugiat. Nunc placerat sapien et metus molestie, in viverra augue viverra. Donec varius metus ut arcu vestibulum hendrerit. Sed viverra risus neque, ac commodo enim lacinia at.
Morbi posuere tortor vitae sapien faucibus auctor. Donec nulla ipsum, aliquet non bibendum sit amet, viverra non metus. Sed blandit efficitur orci, id dignissim eros.
Donec sollicitudin massa ut tellus gravida, ut luctus lacus maximus. Maecenas porttitor a tellus ac sagittis. Suspendisse potenti. Donec mauris sem, tristique a ipsum vitae, pretium facilisis libero. Nullam interdum mauris in euismod pretium. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nunc felis lectus, ornare a nunc eu, convallis suscipit elit. Donec at magna non orci maximus mollis. Cras commodo venenatis lectus vel fringilla.
Proin mollis, magna consequat placerat tempus, lectus dui porttitor augue, eget vulputate orci augue nec nisl. Integer sagittis
Open an account to get
access to more details
Sustainable Competitive Advantage & Competition
Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.
Duis vitae mi neque.
Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.
Proin neque lacus, semper vel ex at, eleifend rhoncus est.
Cras non nisi urna. Sed feugiat dignissim erat, eget convallis nisl blandit a. Nullam fringilla diam eget dui placerat fermentum. Maecenas malesuada viverra leo eu bibendum. Nam vulputate enim velit, eu pretium justo tristique ac.
Nam vitae varius augue. Nam pharetra facilisis elementum. Sed nisl risus, vestibulum ut velit at, dapibus sagittis arcu. Nullam sed dolor suscipit, efficitur enim quis, vestibulum sapien. Nunc convallis mauris nec nibh mollis, eget aliquet odio tincidunt.
Phasellus faucibus sem mauris, sed iaculis nisl egestas sed. Sed sit amet gravida elit, sagittis sollicitudin nulla. Vivamus auctor arcu eu scelerisque convallis. Phasellus scelerisque ultrices tincidunt. Curabitur odio libero, faucibus et felis nec, pulvinar facilisis urna. Interdum et malesuada fames ac ante ipsum primis in faucibus. Maecenas ultrices in velit at ultrices.
Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet. Vivamus maximus nulla volutpat, ornare lorem a, vulputate enim.
In dui nisl, vestibulum eu finibus pretium, eleifend et eros. Vivamus in venenatis risus, ut dictum vel
Open an account to get
access to more details
Highlights & Milestones
Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet.
Vivamus maximus nulla volutpat, ornare lorem a, vulputate enim. In dui nisl, vestibulum eu finibus pretium, eleifend et eros. Vivamus in venenatis risus, ut dictum velit. Praesent rhoncus tempor fermentum. In malesuada tellus eu volutpat posuere. Nullam ut dignissim libero, ut pharetra leo. Nullam sit amet aliquam felis. Suspendisse volutpat ante eget tincidunt feugiat. Nunc placerat sapien et metus molestie, in viverra augue viverra. Donec varius metus ut arcu vestibulum hendrerit. Sed viverra risus neque, ac commodo enim lacinia at.
Morbi posuere tortor vitae sapien faucibus auctor. Donec nulla ipsum, aliquet non bibendum sit amet, viverra non metus. Sed blandit efficitur orci, id dignissim eros.
Donec sollicitudin massa ut tellus gravida, ut luctus lacus maximus. Maecenas porttitor a tellus ac sagittis. Suspendisse potenti. Donec mauris sem, tristique a ipsum vitae, pretium facilisis libero. Nullam interdum mauris in euismod pretium. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nunc felis lectus, ornare a nunc eu, convallis suscipit elit. Donec at magna non orci maximus mollis. Cras commodo venenatis lectus vel fringilla.
Proin mollis, magna consequat placerat tempus, lectus dui porttitor augue, eget vulputate orci augue nec nisl. Integer sagittis vitae nibh vitae finibus. Vestibul
Open an account to get
access to more details
See more exiting opportunities on CapitalHQ
BetterX
BetterX offers B2B and B2B2C white-label and API driven software solutions to traditional institutions to offer digital asset services to their clients.
Paycepaid
Paycepaid is a Software as a Service debt collection solution unlike any on the market today with a heavy focus on the debtor. Empowering businesses to manage their end to end collections while providing debtors with a magnitude of options to reduce financial stress and anxiety.
Wholesale Investor
Wholesale Investor, with over 45,000 subscribers, is a leading private capital marketplace operating across Australia, Singapore, and the UK. It has a 15-year track record of connecting private market opportunities with HNW, professional, and family office investors. In just 4 years, our product...
PRIMAL ORGANIX
Primal Organix has created the world’s first botanically derived Terpene blended anti-anxiety health supplement that manages anxiety in minutes. Our purpose is to support positive mental ill-health and well-being in all human beings.
Sustainable Fintech Fund
Startupbootcamp, the #1 Accelerator in the world outside of the US, established in 2010, operates in 27 countries around the globe, has accelerated over 1600+ startups with a success rate of 76% remaining active, raised over $2.2B in total funding, a network of more than 300+ investors, 5000...
Misio
Sustainability performance and stakeholder communications are now fundamental to overall corporate profitability and impact. Misio simplifies a complex eco-system to help large & listed companies shift the sustainability narrative out from annual reports into easy to understand digital...
Pictor
Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,...
National Property Group
National Property Group (NPG) is a trusted alternative provider of property data and insights empowering informed decisions for all property market participants. NPG relaunched its property data & analytics intelligence platform in 2021, delivering instant insights from more than 40 years of...
Novapep
Novapep, an Australian/US biotech, has developed a patented peptide structure called biparediteTM as an oral inflammatory bowel disease therapy, which will be a cost effective first-in-class drug. Biparetide has been shown in animals to be as effective as expensive, injectable biologic drugs (a...
Backed By Leading Investment Groups and Family Offices
